![NASASBIR/STTR SUCCESS STORIES](https://webarchive.library.unt.edu/eot2008/20090118032908im_/http://sbir.gsfc.nasa.gov/SBIR/successes/ssimage/ssimage.gif) |
Johnson
Space Center
1985 Phase II
Non-Invasive
Hemodynamic Monitoring System
Cardiodynamics International Corporation
San Diego, CA
|
INNOVATION
A hemodynamic patient monitoring
system which enables physicians to rapidly and accurately analyze patient hemodynamic status in a less costly, non-invasive, real-time manner.
|
Cardiac Output Mobile Monitoring System
|
|
ACCOMPLISHMENTS
- Translates electrical conductivity
in the thorax into blood flow data
- Twelve parameters are measured
or derived and displayed in real time, including: cardiac
output/index, two measurements of contractility, systemic vascular
resistance, and thoracic fluid content
|
COMMERCIALIZATION
- The BioZ System (second generation
system), which features advanced digital signal processing, received
FDA approval in November 1996.
- In September 1997, the firm received
FDA approval for the Portable BioZ System.
- The Company has announced that
GE Medical Systems Information Technologies plans to purchase $3.5
million of CardioDynamics' products.
- Recurring revenue for the first
quarter 2001 was $360,000 (9% of sales), an increase of 70% over recurring
revenue of $212,000 for the same period in fiscal 2000.
- The firm has reported it’s 1st
Profitable year (2002), 18th Consecutive Quarter of increased sales
and a 20% increase in third quarter 2001 sales.
|
- Net sales for the third Quarter
of 2002 were 6.3 millions dollars.
- The firm recently announced that
Pfizer Global Research and Development purchased BioZ Systems for
its Research Clinic in the United Kingdom. This represents Pfizer's
second multiple-unit order for its research clinics in Europe.
- The firm has announced that it ranked
287th in the 2003 Deloitte Technology Fast 500, a ranking of the 500
fastest growing technology companies in North America. Rankings are
based on five-year percentage revenue growth from 1998-2002. The firm
has grown revenue 1,021 percent during this period.
GOVERNMENT/SCIENCE
APPLICATIONS
- Procedure provides an easy to
use, non-invasive, cost effective alternative to the Pulmonary Artery
(Swan-Ganz™) Catheter for monitoring cardiac function in government
medical facilities
|
For
more
information
about
this
firm,
please
send
e-mail
to company
representative
Return
to NASA SBIR Success Listings
|
Biomedical/Medical
Curator:
SBIR Support  |